Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

LJP-394 marketing agreement between La Jolla Pharma and Leo Denmark discontinued

May 31, 1996

Zeneca claims prostaglandin E antagonists

May 31, 1996

Merck Frosst Canada reveals cyclooxygenase type 2 (COX-2) inhibitors

May 31, 1996

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Update on ConXn clinical progress

May 24, 1996

COX-2 inhibitors in clinical trials at Merck & Co.

May 24, 1996

COX-2 inhibitor selected for further study at Searle

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

SmithKline Beecham's C-DART approach to rheumatoid arthritis

May 17, 1996

Novel antiarthritics claimed by Procter & Gamble

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...